- Compare Page
Description
Properties
suitable for EPA 1633
suitable for ISO/CEN 15968-2010
suitable for ISO/CEN 15968-2010
sulfate (SO42-): ≤5 ppm
sulfite (SO32-): ≤10 ppm
101 °C/1013 hPa
101 °C/1013 hPa
101 °C/1013 hPa
Ca: ≤10 ppm
Cu: ≤1.0 ppm
Fe: ≤5.0 ppm
K: ≤5.0 ppm
Mg: ≤2.0 ppm
NH4+: ≤10 ppm
Na: ≤5.0 ppm
Ca: ≤0.20 ppm
Cu: ≤0.020 ppm
Fe: ≤2.0 ppm
K: ≤0.10 ppm
Mg: ≤0.50 ppm
Na: ≤0.50 ppm
Al: ≤0.050 ppm
Ba: ≤0.050 ppm
Be: ≤0.020 ppm
Bi: ≤0.10 ppm
Ca: ≤0.20 ppm
Cd: ≤0.050 ppm
Co: ≤0.020 ppm
Cr: ≤0.050 ppm
Cu: ≤0.020 ppm
Fe: ≤2.0 ppm
Ge: ≤0.050 ppm
K: ≤0.10 ppm
Li: ≤0.020 ppm
Mg: ≤0.50 ppm
Mn: ≤0.050 ppm
Mo: ≤0.020 ppm
NH4+: ≤10 ppm
Na: ≤0.50 ppm
Ni: ≤0.050 ppm
Pb: ≤0.020 ppm
Sr: ≤0.020 ppm
Ti: ≤0.10 ppm
Tl: ≤0.050 ppm
V: ≤0.050 ppm
Zn: ≤0.050 ppm
Zr: ≤0.10 ppm
heavy metals (as Pb): ≤10 ppm
57 %
57 %
57 %
Usage and Safety
- Modified QuEChERS method combined with ultra performance liquid chromatography-tandem mass spectrometry for detection of cyclopiazonic acid in feeds: This study demonstrates the use of 98-100% formic acid in a modified QuEChERS method, enhancing the efficiency of toxin detection in animal feeds, crucial for maintaining food safety and environmental health (Peng et al., 2024).
- Adapting Fabric Phase Sorptive Extraction as an Innovative Multitool for Sample Transfer and Extraction in Pharmacokinetic Analysis Followed by LC-MS Determination of Levofloxacin in Plasma Samples: This study utilizes formic acid in developing advanced extraction methods for pharmacokinetic analysis, critical for drug development and therapeutic monitoring in pharmaceutical research (Ekin Dolaksız et al., 2024).
- Stability Indicating Method Development and Validation of Glycyrrhizin Using RP-HPLC-DAD: Application to Glycyrrhiza glabra Extract: This research uses formic acid in chromatographic analyses to ensure the stability and quality of herbal medicine compounds, relevant in both pharmaceutical and biotechnological fields (Lyngdoh et al., 2024).
Danger
Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Eye Dam. 1 - Flam. Liq. 3 - Skin Corr. 1A
3 - Flammable liquids
WGK 1
121.1 °F - closed cup
49.5 °C - closed cup
Danger
Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Eye Dam. 1 - Flam. Liq. 3 - Skin Corr. 1A
3 - Flammable liquids
WGK 1
121.1 °F
49.5 °C
Danger
Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Eye Dam. 1 - Flam. Liq. 3 - Skin Corr. 1A
3 - Flammable liquids
WGK 1
121.1 °F - closed cup
49.5 °C - closed cup
Danger
Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Eye Dam. 1 - Flam. Liq. 3 - Skin Corr. 1A
WGK 1